Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Renal Cell × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 Medication Adherence 1 Margins of Excision 1 Lymphoma, Follicular 1 Lymphedema 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Early-stage Peripheral Non-small Cell Lung Cancer 1 Depression 1 Dementia 1 Cognitive Dysfunction 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Breast Cancer Female 1 Anxiety Disorders 1 Alzheimer Disease 1

Interventions

Nivolumab 66 Sunitinib 63 pembrolizumab 40 cabozantinib 34 Everolimus 33 Sorafenib 32 pazopanib 31 Axitinib 31 Bevacizumab 30 Radiosurgery 29 Ipilimumab 29 Magnetic Resonance Spectroscopy 25 Interleukin-2 23 aldesleukin 21 Specimen Handling 18 Cyclophosphamide 17 lenvatinib 16 fludarabine phosphate 15 Radiotherapy 15 Interferon-alpha 15 temsirolimus 13 Peripheral Blood Stem Cell Transplantation 13 Biopsy 13 Nephrectomy 12 Gemcitabine 12 Blood Specimen Collection 10 durvalumab 9 Immunohistochemistry 9 Capecitabine 9 Mycophenolic Acid 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01967407 2014-11-19

IRENE

University of Magdeburg

Phase 1/2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡